Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid TumorsJulius Strauss, James L. Gulley, Ravi A. Madan et al.|Clinical Cancer Research|2018Cited by 415
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placeboThomas Dirschka, Peter Radny, R. Dominicus et al.|British Journal of Dermatology|2011Cited by 181